FDA Inspection 1131910 — Quagen Pharmaceuticals LLC
The FDA completed an inspection of Quagen Pharmaceuticals LLC on Oct 26, 2020 in West Caldwell, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 26, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- West Caldwell, NJ (United States)